DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Cannabinol is an investigational drug.
There have been 44 clinical trials for Cannabinol. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2009.
The most common disease conditions in clinical trials are Marijuana Abuse, Chronic Pain, and Abdominal Pain. The leading clinical trial sponsors are Yale University, National Institute on Drug Abuse (NIDA), and Radboud University.
Recent Clinical Trials for Cannabinol
|INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa||InMed Pharmaceuticals Inc.||Phase 2|
|Cannabis Use, Cognition, and the Endocannabinoid System in HIV||National Institute on Drug Abuse (NIDA)||Early Phase 1|
|Cannabis Use, Cognition, and the Endocannabinoid System in HIV||University of California, San Diego||Early Phase 1|